HealthQuartzabout 1 hour ago
Merck CEO expects faster personalized cancer vaccine
2 min read
Merck CEO Rob Davis told CNBC on Wednesday that the personalized cancer vaccine developed with Moderna will become faster to manufacture over time. The current process takes six weeks from tumor sequencing to hospital delivery. Davis described the manufacturing as a complex system but noted the companies are driving for improvement to shorten the timeline for this unprecedented technology.
Level
Hype check
Tap to vote and see what everyone thinks.